LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks ...

LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer and the MindBody GLP-1 System. The findings reveal that when used ...

LifeVantage (LFVN) hosted its annual Global Kickoff on Saturday, January 11, 2025. The company also announced that the Philippines, Taiwan, ...

SALT LAKE CITY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products ...

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company focused on nutrigenomics and wellness products with a market capitalization of $282 million, has announced the ...

LifeVantage Corporation hosted its annual Global Kickoff on January 11, 2025, drawing thousands of independent Consultants to celebrate the company’s vision for the year, focusing on momentum ...

"Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding execution by our team to ...

SALT LAKE CITY - LifeVantage (NASDAQ:LFVN) Corporation (NASDAQ:LFVN), a company focused on nutrigenomics and wellness products with a market capitalization of $282 million, has announced the global ...